In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


LifeSync Holdings Inc

Latest From LifeSync Holdings Inc

LifeSync Corp.

LifeSync is discovering that the introduction of its wireless electrocardiogram (ECG) data communication system, which eliminates the lead wires of traditional ECG systems, while not necessarily enabling remote communications, is bringing clinical and economic advantages to hospitals.
Medical Device

An Early Peek at Glaucoma Devices

The clinical community has long been searching for a safe and effective surgical alternative to drugs for glaucoma, but the field has moved slowly. A decade ago, non-invasive laser procedures began earning a place as a second-line therapy with limited durability. Invasive surgeries are reserved for end-stage glaucoma because of their complexity, their serious complications, and their high failure rates. Venture firms believe a large, unmet clinical need represents a new $1 billion device market, and the pace of glaucoma device company creation is picking up.
Medical Device

Clinical Laboratories' Amazing Comeback

A variety of factors, ranging from consolidation to the emergence of genomics, has helped resurrect clinical labs from near death. The nation's two largest labs, LabCop. and Quest, have seen their stock prices shoot up a staggering 600% in the past three years, while a cadre of more specialized labs has ridden their coattails. These labs are looking to genomics to sustain their renaissance, as existing drivers shift and maintaining their growth rate gets tougher.
Medical Device Strategy

Genomics Squatter

Armed with a purification technology it uses to isolate human DNA from the much more abundant nonhuman DNA found in stool samples, Exact Sciences is taking already-known disease-associated genomics markers into the clinical diagnostics setting. With the May announcement of the availability of its first test, for a rare form of colorectal cancer, the company is gaining visibility and traction.
Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • GMP Companies Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • LifeSync Holdings Inc
  • Senior Management
  • Bart M Chernow, MD, Pres. & CEO
    Holger Weiss, CFO
    Guido E Smeets, MD, VP, R&D
    Nancy Struzziero, Dir., Sales
    Edwin A Rodriguez, Dir., Bus. Dev.
  • Contact Info
  • LifeSync Holdings Inc
    Phone: (954) 745-3510
    1 East Broward Blvd.
    Ste. 1701
    Ft. Lauderdale, FL 33301